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AIM OF THE STUDY: 
Various combinations of drugs have been tried for smooth insertion of LMA in 
children This study compares the ideal insertion conditions for Laryngeal Mask Airway 
(LMA) with Ketamine versus Fentanyl with Propofol in children and to study the 
haemodynamic response with both the drugs. 
ABSTRACT: 
  The ideal combination that provides smooth insertion conditions with minimal 
side effects has not been identified, particularly in children. In this study, 70 children of 
age 3-12 years are divided randomly into 2 groups: Group 1-Group-F-Fentanyl (n=35) 
received Fentanyl 2µg/kg and Group 2-Group –K- Ketamine (n=35) received Ketamine 
0.5mg/kg before induction of anaesthesia..Baseline heart rate and arterial blood pressure 
were measured. Vital parameters (Heart rate and Arterial Blood Pressure) were measured 
before induction, before LMA insertion and thereafter at 1, 3 and 5 minutes after LMA 
insertion. Ideal LMA insertion conditions were evaluated with six variables by blinded 
observer: mouth opening, gagging, .head and limb movements, laryngospasm and 
resistance to insertion. Also the apnoea time was noted. 
RESULTS: 
The incidence of head/limb movements was statistically significant and Group 
Propofol – Ketamine showed 22% compared to Fentanyl-Propofol group (2.8%) 
Coughing/gagging was seen in 2.86% of both the groups. Resistance to insertion was 
statistically significant with p value of 0.0268 showing more in Propofol + Ketamine. 
There was no statistical significance in the occurrence of restricted mouth opening, 
restriction to LMA insertion and occurrence of swallowing between the two groups. 
Laryngospasm was absent in either groups. Fentanyl group showed the incidence of more 
apnoea (34.28) compared to Ketamine group (14.2).The heart rate (HR  ),systolic blood 
pressure(SBP), diastolic blood pressure(DBP) and mean  arterial pressure(MAP) were 
statistically more with  Ketamine group than Fentanyl group. 
CONCLUSION: 
Co-induction with Fentanyl (2µ/kg) prior to Propofol (2.5mg/kg) induction for 
insertion of Laryngeal Mask Airway in children provided better insertion condition with 
minimal increase in heart rate, systolic blood pressure, diastolic blood pressure and mean 
arterial pressure than admixture of Ketamine (0.5mg/kg) with Propofol . 
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INTRODUCTION 
To master in anaesthesia profession, airway management is one of the 
most important skills. For securing patients airway under anaesthesia and 
providing adequate oxygenation and ventilation, various airway devices have 
become available. Undoubtedly, the endotracheal intubation is the definitive 
way of securing the airway. But this needs the usage of neuromuscular 
blocking agents and has its own side effects. Bag and mask ventilation may be 
used for providing anaesthesia for short surgical procedures. 
Since the introduction of Laryngeal Mask Airway (LMA) by 
Dr.ARCHIE BRAIN, LMA has gained popularity among anaesthetist in 
securing and maintaining spontaneous ventilation in short surgical procedures 
bridging the gap between the endotracheal tubes and facemask. It frees the 
anaesthesiologist’s hands for performing other important tasks, lesser incidence 
of airway injury and minimal cardiovascular and haemodynamic response. 
Commonly, Propofol is used as induction agent for LMA insertion. The 
LMA insertion requires adequate depth of anaesthesia for obtundation of 
airway reflexes and also it has to be tolerated without undue coughing, bucking 
or laryngospasm. Many combinations of drugs have been tried for ideal LMA 
insertion conditions. Here, we have done a comparative evaluation of the 
conditions for LMA insertion with Ketamine versus Fentanyl adding Propofol 
in spontaneously breathing children undergoing day care procedures 
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AIM OF THE STUDY 
To compare and estimate ideal insertion conditions for Laryngeal- Mask 
Airway with Ketamine versus Fentanyl adding Propofol in spontaneously 
breathing children undergoing day care procedures. 
To observe haemodynamic and other response to both drugs. 
The main objectives are: 
1. Laryngeal Mask Airway ideal insertion conditions 
2. Number of attempts at LMA insertion 
3. Haemodynamic changes 
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AIRWAY ANATOMY 
The airway is divided into the upper airway, that starts from nose to the 
glottis and the lower airway that comprises trachea, bronchi and bronchial 
subdivisions. 
Pharynx is 12 to 15 cm long, starts from base of skull upto cricoid cartilage 
anteriorly and ends posteriorly upto inferior border- C6 vertebra. 
The pharynx is subdivided into 
 Naso-pharynx - has respiratory function, starts from posterior end of 
turbinates and nasal septum and ends at soft palate. 
 Oropharynx - has digestive function  
Extends inferior to soft palate and ends at upper part of epiglottis. 
 Laryngopharynx – is between C4-C6 vertebrae, extends from upper 
border of epiglottis to the lower border- cricoid cartilage. 
Pharynx acts as a shared pathway for both digestive and respiratory 
system. So, pharyngeal patency is important to maintain the patency of the 
airway and proper gas exchange in unintubated patients. 
Tongue falling back onto the posterior pharyngeal wall has been 
postulated traditionally as the major cause of upper airway obstruction, who are 
anaesthetized or who have decreased level of consciousness. Reduction in the 
tone of genioglossus muscle leads to obstruction, when tongue is displaced 
posteriorly. 
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 Six skeletal muscles namely: 
Tensor-velipalatini, musculusuvulae, palateglossus, palatopharyngeus 
and superior constrictor muscle constitute velopharyngeal sphincter. The good 
function of the sphincter is essential for adequate airflow through nasal 
passages during normal breathing and deglutition. 
Recently velopharyngeal segment next to soft palate has become the 
primary focus. 
Many studies have found that the anteroposterior dimensional changes 
in the upper airway occur also at the level of soft palate and epiglottis causing 
upper airway obstruction than the tongue. 
Major differences between paediatric and adult airway are- 
 Larynx is more anterior and cephalad 
 Relatively large tongue 
 Angled vocal cords 
 Epiglottis is large floppy and more cephalad 
 Funnel shaped larynx. 
 Narrowest part of paediatric airway is cricoid cartilage 
Thus understanding of airway anatomy is essential for maintaining 
airway patency in the conduct of anaesthesia either under intravenous or 
inhalational agents. 
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LMA AND PAEDIATRIC PATIENT 
LMA usage avoids the potential trauma of endotracheal intubation as the 
infant larynx is delicate. It is preferable for airway management in paediatric 
patients for short procedures. The LMA is the best device in certain situations, 
when there is difficulty in holding the mask, and also for surgeries on head and 
neck. For many procedures such as diagnostic or quick peripheral procedures 
requiring administration of anaesthesia, LMA can be used as opposed to face 
mask or endotracheal intubation. 
Advantages in using LMA are better haemodynamic stability, decreased 
anaesthetic requirement, avoiding muscle relaxants, reduced cough and sore-
throat. LMA has been extensively used as an ideal and protective airway 
device, for patients who are maintaining spontaneous breathing under 
anaesthesia. Major constraint in the use of LMA is positive pressure 
ventilation, which may landup with pulmonary aspiration. 
Specific uses of LMA in paediatric population 
 Radiation therapy 
 Computed Tomographic Scanning 
 Magnetic Resonance Scanning 
 New born resuscitation 
 Diagnostic flexible bronchoscopy 
Best suitable for use where tracheal intubation is not necessary for 
elective surgical procedures. 
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A rescue device for failed intubation and “Cannot Ventilate Cannot 
Intubate” situations 
It is an accepted alternative in cardiopulmonary resuscitation (CPR), to 
have instant, patent airway in unconscious patients (impaired airway reflexes) 
demanding controlled ventilation. 
Contraindications include 
1. Full stomach 
2. Grossly or morbidly obese 
3. Restricted mouth opening 
4. Upper airway obstruction 
5. Known or suspected abnormalities in supraglottic anatomy 
6. Patients with diminished pulmonary compliance, or peak inspiratory 
pressure exceeding 20 cm H2O, because the device forms a low pressure 
seal around the larynx.  
The LMA has revolutionized the difficult airway management. It can 
evade obstruction at supra-glottic level and enable rescue oxygenation & 
ventilation, only if mouth opening is adequate. The LMA can be inserted 
totally deflated when there is inadequate working space. LMA can be used 
efficaciously in conditions like Pierre-Robin syndrome, head and neck 
malformations, Goldenhar syndrome, Treacher-Collins, and 
mucopolysaccharidoses. 
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The success rate of paediatric LMA placement with first attempt, differs 
greatly. There are various techniques of LMA insertion, that implies proper 
placement of LMA is not always possible.  
They are: 
i. With the thumb and index finger ,the LMA is directed along the hard 
palate, in the midline with the cuff being partially inflated or completely 
deflated allowing the tip of the LMA against posterior  pharyngeal wall; 
ii. Using a modified preconfigured styletted LMA; 
iii. Introducing a partially inflated LMA, 45° along the side of tongue, 
progressing until resistance is met and then rotating back into midline; 
iv. LMA is introduced with its cuff directed towards the palate and rotated 
180° as it enters into hypo pharynx— similar to inserting an adult-
Guedel airway. 
The last two methods are suggested to prevent the tongue being pushed 
into the hypo-pharynx and aids in maintaining the airway patency. Multiple 
insertion attempts may increase the incidence of postoperative sore throat. 
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Confirmation of LARYNGEAL MASK AIRWAY placement is by 
1. After cuff inflation especially in classic LMA ,LMA comes out of  
about 1cm 
2. On manual ventilation there will be good chest movement 
3. Capnography showing square wave tracing 
4.  Movement of the Reservoir bag during spontaneous and assisted 
ventilation 
5. Auscultating over the neck 
6. Absence of audible leak at peak airway pressure of 20 cm H2O  
7. Expiratory tidal volume and flow volume loops 
8. Checking with fibre-optic bronchoscope. 
The visual inspection of chest rise and ETCO2 are the most commonly 
practiced methods. 
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The LMA is made of medical grade silicone and doesn’t contain latex. It 
comprises of an expandable mask, fixed with a tube that exits through mouth to 
enable ventilation. The Mask fits against the tissues of the peri-glottic region 
and occupies the hypopharyngeal space. It forms a seal above the glottis rather 
than within the trachea. The Aperture bars prevent the epiglottis from 
obstructing the airway tube. 
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STANDARD INSERTION TECHNIQUE: 
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CHARACTERISTICS OF LMA OF DIFFERENT SIZES: 
LMA 
SIZE PATIENT SIZE 
Max. Cuff 
inflation 
(mL) 
Max. ETT to 
be fit (ID in 
mm) 
Max. 
Fiberoptic 
scope for the 
ETT (mm) 
1 Neonates / infants (upto 5 kg) 4 3.5 2.7 
1.5 Infants(5-10kg) 7 4 3.0 
2 Infant, children(10-20kg) 10 4.5 3.5 
2.5 Children(20-30kg) 14 5.0 4.0 
3 Children(30-50 kg) 20 6.0cuffed 5.0 
4 Adults (50-70kg) 30 6.0cuffed 5.0 
5 Adults 70-100 kg 40 7.0cuffed 5.0 
6 Adults > 100kg 50 7.0cuffed 5.0 
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Complications include 
 Laryngospasm, bronchospasm 
 Trauma to the airway 
 Regurgitation and aspiration 
 Incorrect placement including folding over of the tip, can lead to 
inadequate ventilation and pulmonary oedema 
 Cuff malfunction 
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THE PHARMACOLOGY OF INTRAVENOUS ANAESTHETIC 
INDUCTION AGENTS 
Intravenous anesthetic agents are commonly used to achieve induction, 
for conduction of general anaesthesia and to have adequate sedation. To 
improve the safe practice of anaesthesia, the goal of an anaesthesiologist should 
be of inducing anaesthesia without significant side effects. 
General anaesthesia comprises of analgesia, amnesia, hypnosis and 
immobility, associated with suppression of autonomic reflexes.  
Characteristics of an ideal anaesthetic drugs are: 
Pharmacodynamic/pharmacokinetic properties 
1. Causing hypnosis and amnesia 
2. Quick onset  
3. Rapidly metabolised to inactive forms 
4. Negligible cardiovascular and respiratory effects 
5. Absence of histamine release and hyper-sensitivity reactions 
6. Non toxic, non mutagenic, non carcinogenic 
7. No untoward neurologic effects like seizure, myclonus, neurotoxicity 
8. Other beneficial effects analgesic, antiemetic, neuro protection, 
cardio protection 
9. Pharmacokinetic established prototypes to guide precise dosing 
10. Continuous monitoring of delivery 
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Physio chemical features 
1. Water Soluble  
2. Stable formation, non pyrogenic 
3. Non irritating, absence of pain due to iv- injection 
4. Less volume required for injection 
5. Economical to prepare & formulate 
6. Anti-microbial properties 
No currently available drug achieves all these criteria. 
Recent concepts propose that, amnesia comprises of alteration in the 
plasticity of hippocampal synapses, loss of consciousness includes disturbance 
of thalamo-cortical communications and immobility involving decreased spinal 
reflexes. 
The chief objectives of i.v anaesthetic drugs are ionotropic (ion channel 
linked) receptors of the endogenous neurotransmitter-glutamate {major 
excitatory neurotransmitter} or GABA - primary inhibitory neurotransmitter. 
Mature neuronal membranes are hyperpolarized by GABA receptor 
mediated chloride and bicarbonate anion conduction and are the principal 
objectives of the anaesthetic agents of all IV anaesthetics and sedatives except 
Ketamine.Ionotropic glutamate receptors are classified as NMDA and Non 
NMDA types.  
Competitive blockade of NMDA receptors is the principal mechanism 
for Ketamine – a dissociative anesthetic.  
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PROPOFOL 
Propofol is an achiral, lipophilic substitute, disopropyl phenol           
(2,6-diisopropyl phenol). 
It is an insoluble drug that requires a lipid vehicle for emulsification. It 
is available as 1% solution for intravenous use- aqueous solution of 10% soya- 
bean oil, 2.25%- glycerol and 1.2% -purified egg phosphatide. This formulation 
supports bacterial growth and causes increased plasma triglyceride 
concentration when prolonged IV infusions are utilized. 
Structure of PROPOFOL: 
 
 
The Propofol Emulsion is injectable -isotonic &with pH - 7 to 8.5. 
Mechanism of action Propofol interaction with specific components of 
GABA A receptors causes a decrease in the dissociation rate of the 
neurotransmitter- GABA (inhibitory) from its receptor thereby prolonging the 
interval of the GABA stimulated opening of the chloride channel leading to 
hyper polarization of cell membranes. 
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Pharmacokinetics: 
 A very weak acid ,non-ionized at physiologic pH, with pKa 11 
 Consistent with three compartment model 
 High hepatic extraction, rapid and extensive. Undergo ring 
hydroxylation by cytochrome P-450 to form 4-hydroxypropofol 
which has 1/3rd hypnotic activity of Propofol. 
 Elimination half time 30-90 mins 
 For infusions lasting for 8 hours the Context sensitive half time is 
<40 mins 
 Has a short effect-site equilibration time 
 .Children require higher induction dose reflecting a larger central 
distribution volume and higher clearance rate. 
 Volume of distribution is 3.5 - 4.5 L /kg with clearance of  
30-60 ml/kg/min 
 No evidence of impaired elimination in liver disease patients  
Pharmacodynamics: 
 Produces unconsciousness within about 30 seconds acting on    
GABA-A receptors 
 Decrease in systemic blood pressure due to blockade of sympathetic 
vasoconstrictor activity producing relaxation of vascular smooth 
muscle. 
 18 
 Effectively blunts the hypertensive response to direct laryngoscopy, 
tracheal intubation and of placement of LMA due to central 
neurological depression of airway protective reflexes  
 Decreases cerebral metabolic rate, cerebral blood flow and intra 
cranial pressure. 
 May cause bradycardia and asystole.(may require isoproterenol as 
treatment) 
 Produces dose dependant depression of ventilation with apnoea 
 HPV seems to remain intact  
 Spontaneous excitatory movements common during induction and 
recovery 
 Anti-emetic  
 Anti-pruritic  
 The more rapid return of consciousness with minimal residual CNS 
effects 
Clinial uses 
 Suitable solution: 1% isotonic emulsion, not bacteriologically stable- 
do not store > 6 hours at room temperature; To avoid pain while 
injecting Propofol add 1% lignocaine to Propofol in the ratio of 1:20 
 Induction drug of choice 
 Commonly used for conscious sedation  
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 Induction dose: 
o 1-4years:3-4mg/kg 
o >4 years: 3.5mg/kg 
o Adults: 1.5 – 2.5mg/kg 
o Unconsciousness within about 30 seconds 
o Duration of action – 5 to 10 mins 
 Continuous infusion :  
o Maintenance dose 100 to 300 µ/kg/min 
Adverse effects: 
 Cardiovascular : hypotension, arrhythmias 
 Respiratory: respiratory depression, apnoea, laryngospasm, 
bronchospasm, hiccups 
 Neurological: headache, confusion, atypical seizure like movements, 
opisthotonus 
Propofol Infusion Syndrome : 
 Characterised by severe metabolic acidosis, hyperkalemia, lipemia, 
rhabdomyolysis and hepatomegaly, may lead to cardiac and renal 
failure.  
 Major risk factors: severe neurological damage with or without 
sepsis, increased dosage of vasoconstrictors, steroids, inotropes or in 
patients getting continued high dose infusions of >75mcg/kg/min for 
more than 24 hrs. 
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FENTANYL 
Fentanyl citrate is N-(1-phenethyl-4piperidyl) propionanilide citrate 
(1:1) has a molecular weight of 528. 60, structurally related to Pethidine. 
Structure of Fentanyl: 
 
 
Mechanism of action 
Opioids acts at two sites namely the pre-synaptic and post-synaptic 
nerve terminals. Postsynaptic actions are usually inhibitory. The primary effect 
in the central nervous system is the inhibition of neuro transmitter release at the 
pre-synaptic nerve terminal. The net effect of opioid has its action at the 
presynaptic nerve terminals by inhibiting the release of both inhibitory and 
excitatory neurotransmitters, whereas at the post synaptic neurons it has 
inhibitory effect, so that the occurrence of excitatory effects may not follow. 
The net actions of opioid on the neurons depend upon the site and 
concentration of receptors. 
Fentanyl is a potent µ opioid agonist, 70-125 times greater than that of 
Morphine. 
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Pharmacokinetics: 
  It is a Weak base,  
  10% of molecules at physiological pH are un-ionized with pKa 8.4 
 Considerably it is more lipid soluble(580), with respect to 
Morphine(1) and, has a more faster onset of action. 
 Consistent with three compartment model 
 Short duration of action, because of rapid re-distribution from brain 
to other structures like skeletal muscles and fat. 
 Terminal elimination half life : 3.1-6.6 hrs 
 Effect site (Blood/Brain equilibration) time is 6.8 mins 
 Volume of distribution is 4L/kg, with clearance of 0.8-1ml/kg/min 
 Context sensitive half time for infusions lasting up to 4 hours is 260 
mins 
 Predominantly metabolized in the liver by hepatic cytochrome P450-
CYP3A to nor-fentanyl, which is inactive, excreted in the urine over 
few days. 
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Pharmacodynamics: 
The principal beneficial activity are analgesia and sedation. 
 
 The onset of action of Fentanyl is almost immediate when the drug is 
given intravenously. 
  100μg of Fentanyl has nearly the same analgesic activity when 
compared to 10 mg Morphine  
 Effectively blunts the hypertensive response to direct laryngoscopy, 
tracheal intubation and for placement of LMA 
 Lack of myocardial depressant effects 
 Absence of histamine release 
 Suppresses stress responses to surgery 
 Fentanyl commonly reduces the respiratory rate, the effect being 
dose dependent. The peak effect of respiratory depression is seen 5-
15 minutes after single IV dose of Fentanyl. 
  Duration of the analgesic action – 
 I.V: 30-60 min after a single IV. dose of 100 μcg .  
 I.M: onset is 7 to 8 minutes, and duration of effect lasting for 
1-2 hrs. 
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Clinical uses: 
 
  For shorter surgical procedures to achieve good analgesic effects, 
  As pre-medicant. 
  As inducing agent and for maintenance of general anaesthesia 
 In the immediate postoperative period for pain relief 
 Used as supplement opioid analgesic in regional anesthesia.  
 For neuroleptic anaesthesia 
 Used in high risk patients for undergoing open -heart surgery or 
certain major neurological or orthopedic surgical procedures 
 Administered clinically in a wide range of doses  
Low dose to provide analgesia: 1-2 μg/kg 
Moderate dose: 2-20 μg/kg, for major surgery also causes 
abolition of stress response 
 High dose: 20-50 μg/kg, for open- heart surgery and certain 
major neuro-surgical and orthopedic surgical procedures  
 
For children 2-8 years of age pre-op administration of oral transmucosal 
Fentanyl, 15-20 μg/kg 45 mins before induction of anaesthesia, induces 
preoperative sedation and facilitates induction of inhalation anaesthesia. 
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Adverse effects: 
 To be used cautiously in 
o COPD patients,  
o patients with reduced respiratory effort with poor lung 
function, 
o with liver &kidney dysfunction, 
o with cardiac bradyarrhythmias.( as it produce bradycardia) 
 
 The most common side effects that are encountered are chest wall 
rigidity, apnoea, respiratory depression and bradycardia 
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Ketamine 
Ketamine is a phencyclidine derivative. It doesn’t require a lipid 
emulsion vehicle. It produces profound analgesia at sub-anaesthetic doses. The 
preservative used for Ketamine is benzethonium chloride. 
The racemic form of Ketamine has been the most frequently used 
preparation with left handed optical isomer S(+) and right handed optical 
isomer R(-) 
Structure of Ketamine 
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Mechanism of action: 
Ketamine binds noncompetitively with NMDA receptors, thereby 
inhibiting NMDA receptor activation by glutamate, decreases presynaptic 
release of glutamate, and potentiates the effect of inhibitory neurotransmitter 
GABA. 
Pharmacokinetics: 
 Consistent with two compartment model 
 Rapid onset of action  with moderate lipid solubility  
 pK of 7.5 at physiologic pH 
 High hepatic clearance -1lit/min 
 Large volume of distribution -2.5-3.5L/kg 
 Elimination half-time of 2-3hrs 
 Undergoes demethylation by CYP-450 to form norketamine which is 
1/5th -1/3rd as potent as Ketamine 
Pharmacodynamics: 
 Produce intense analgesia with subanaesthetic dose, amnesic, 
relatively poor hypnotic 
 Produce dissociative anaesthesia in which patient appear awake, eyes 
remain open with cough, swallow and corneal reflexes present 
 Increases muscle tone, salivation, lacrimation, nystagmus 
 Increases cerebral metabolism, blood flow and intracranial pressure 
 27 
 Produces cardiovascular effects that resemble sympathetic nervous 
system stimulation 
 Has bronchodilatory activity 
 Upper airway reflexes remain relatively intact 
 Higher incidence of emergence delirium 
Clinical use 
Chemically and bacteriologically stable for more than 24 hours at room 
temperature 
 Analgesic dose: 0.2 to 0.5 mg/kg 
 Induction dose: 1 to 2 mg/kg iv or 4 to 8 mg/kg im 
 Single IV dose: consciousness lost in 30-60 secs 
 Single IM dose: consciousness lost in 2-4 mins 
 Return of consciousness :in 10-20 mins 
 Return of full orientation: take 60-90 mins 
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REVIEW OF LITERATURE 
1. In 2000, E. W. S. Cheam and P. T. Chui4 have done a comparative study 
to evaluate the LMA insertion conditions among 150 spontaneously 
breathing adult patients receiving Fentanyl, Mivacurium or Normal 
Saline Group I received Fentanyl 1µ/kg, Group II received Mivacurium 
0.04mg/kg and Group III received Normal saline before Propofol 
induction of 2mg/kg. Using a three-point scale, they graded insertion 
conditions. They concluded that, both the study drugs facilitated equally 
effective LMA insertion conditions with prolonged apnoea compared to 
placebo. 
 
2. In 2002, Bahk JH2 and colleagues have done a comparative study of 
Ketamine and Lidocaine spray using Propofol for the LMA insertion in 
children.  
They examined whether that pre-treatment with Lidocaine spray, 
Ketamine anaesthesia, and LMA insertion could be used as airway 
management that could maintain spontaneous breathing in children. 
They divided the sample in to 2 groups, : 40 patients received 2.5, 3, 3.5, 
or 4 mg/kg of Propofol,(n=10 each) 50 patients received 2.5, 3, 3.5, or 4 
mg/kg of Ketamine IV (n=10 each). Lidocaine spray was used in oro-
pharynx only for Ketamine group, 1 min -before anaesthesia induction 
After induction, jaw relaxation and airway patency were checked. The 
patient’s response to LMA insertion like coughing, gagging, 
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laryngospasm, swallowing, biting or tongue movements were observed. 
All variables were categorized as satisfactory, acceptable, or 
unsatisfactory 
Satisfactory or acceptable outcomes were attained only in the Ketamine 
3.0 or 3.5 mg/kg subgroups. Apnoea and airway obstruction were the 
side effects with Propofol. Ketamine and Lidocaine spray were suitable 
for LMA insertion, in children for managing difficult airway. 
They concluded that Ketamine with Lidocaine spray appear to be suitable 
for laryngeal mask- airway (LMA) insertion in children. Therefore, 
apnoea and airway obstruction, most severe and common complications 
of Propofol, can be avoided at the time of LMA insertion. 
 
3. In 2003, T.Goyagi9 and his colleagues have conducted a study and found 
that Fentanyl reduced Propofol requirement for laryngeal mask-airway 
insertion. 
The study was conducted among 40 healthy patients, with Group F –
Fentanyl-2 µg/kg intravenously(n=20) and control group received equal 
volume of normal saline. To avoid Propofol injection pain, 2% Lidocaine 
– 3ml was given intravenously. A pre-calculated dose of 1% Propofol 
was given in the rate of 100 mg/ min, 30 secs-after Fentanyl or Saline 
injection. LMA was inserted 90s after the completion of injection 
Propofol. 
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The dosage of Propofol was considerably less in Fentanyl group 
compared to control group. 
They concluded that the Propofol requirement for LMA insertion 
decreased with pre administration of Fentanyl 2 µg/kg. 
 
4. Kodaka. M13 and his colleagues have conducted and published a study in 
2004. They did a study of Fentanyl dose and predicted EC 50 (the 
effective concentration for 50% of attempts to proper placement of 
LMA) with Propofol using target controlled infusion. 
They divided 64 adult patients under 4 groups having 16 in each group 
and Fentanyl was given in the dose of 0.5,1 or 2 µg/kg and control group 
receiving saline. The EC 50 for LMA insertion was determined with the 
mentioned doses of Fentanyl and they concluded that 0.5µg/kg of 
Fentanyl is adequate to have a reduced EC 50 LMA with less respiratory 
depression and not much increased BIS value. 
 
5. In 2005, Goh PK8 and colleagues made a comparative study of Ketamine 
+ Propofol, Fentanyl + Propofol and Propofol + saline on haemodynamic 
and laryngeal mask airway insertion conditions among 90 adult patients. 
They divided the sample in to 3 groups; PK (Propofol with Ketamine) 
n=30 with Ketamine 0.5mg/kg,PF(Propofol with Fentanyl)n=30 with 
Fentanyl 1µg/kg and PS (Propofol with Saline) n=30. Induction done 
using Propofol 2.5mg/kg. LMA insertion was done, 60s after injecting 
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Propofol. Arterial blood pressure (BP) and heart rate(HR) were measured 
before-induction (baseline), immediately after induction, immediately 
before LMA insertion, immediately after LMA insertion and every 
minute for three minutes after LMA insertion. After LMA insertion, the 
following end-points were categorized: mouth opening, gagging, 
swallowing, movement, laryngospasm and ease of insertion. Systolic 
blood-pressure(SBP) was more with Ketamine compared to Fentanyl (P 
= 0.010) or saline (P = 0.0001). 
The overall insertion conditions were comparable in the Ketamine and 
Fentanyl groups. Both appeared considerably superior than the saline 
group. The occurrence of sustained apnoea (> 120s) was greater in the 
Fentanyl group [23.1% (7/30)] compared with the Ketamine [6.3% 
(2/30)] and saline groups [3.3% (1/30)]. 
They concluded that adding Ketamine 0.5mg/kg improves 
haemodynamics when compared to Fentanyl 1 µg/ kg, with less 
prolonged apnoea, and is associated with better LMA insertion 
conditions than placebo (saline). 
 
6. In 2008, Goel S7 et al, have compared the efficacy of Ketamine and 
Midazolam as induction agents using Propofol for LMA insertion among 
60 ASA I/II children undergoing day care procedure. They divided the 
sample in to 3 groups: group P-Propofol alone, PK group—Ketamine 
with Propofol and PM group—Midazolam with Propofol. They 
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compared ideal LMA insertion characteristics, hemodynamic changes 
and the duration of recovery. 
In their study they found that , children of PK & PM group had ideal 
insertion situations for inserting LMA compared to group P(P<0.05). 
Also children in group P,showed significant greater decrease in systolic 
blood pressure(SBP) compared to group PK and PM (P<0.005).The drop 
in systolic blood pressure (SBP) in group P was 89% compared to 5% in 
group PK and PM. 
 
7. In 2010, Renu Sinha16 and colleagues have done a clinical trial, 
comparing Propofol (1%) vs Thiopentone (1.25%) +Propofol (0.5%)for 
laryngeal mask airway insertion in children undergoing elective 
ophthalmic surgery. 
This study has been designed to investigate whether this admixture can 
be a suitable substitute to Propofol, with respect to ease of LMA 
insertion, haemodynamic stability, pain on injection, cost containment 
and recovery in children. 
This study included 50 ASA 1 & 2 patients of 3 – 15 years and with 
weight more than 10 kg  
They divided the sample into two groups; Group P-Propofol 1%, group 
Ad received - Thiopentone 1.25% +Propofol 0.5% (1:1). All the patients 
were assessed for the incidence of apnoea, adequate jaw relaxation, pain 
on injection, ease of  LMA insertion, coughing, gagging, laryngospasm, 
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involuntary limb movements, and incidence of hypotension & recovery  
Recovery was more rapid in group P compared to group Ad. They 
concluded that for LMA insertion in children, admixture of Propofol with 
Thiopentone as a mixture was cost effective, suitable and better 
substitute compared to Propofol alone. 
 
8. In 2010, Priyesh Baskar14 and his colleagues have done a study on the 
effect of Midazolam as premedication with respect to the dose of 
Propofol for Laryngeal Mask Airway insertion in children. 
The study included 120 children of ASA Grade I & II of aged 3-12 years 
posted for pediatric surgeries under general anaesthesia. 
All children were randomly separated into Group A and Group B.  
Group A was again separated into 3 subgroups of un-premedicated 
patients who received 3, 4 and 5 mg/kg. Propofol only designated as A1, 
A2 and A3 respectively. Group B was further divided into subgroups of 
premedicated patients with Midazolam (0.05 mg/kg) intravenous and 
received 3, 4 and 5 mg/kg Propofol designated as B1, B2 and B3 
respectively. 
The adverse events like inadequate jaw relaxation, limb movements, 
coughing, gagging and laryngospasm decreased with increasing dose of 
Propofol. Reduction in the adverse events and ideal insertion 
environment was provided when Midazolam was added to Propofol. 
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Propofol, at higher doses (5mg/kg) produced hypotension due to its 
cardiovascular depressant effect, which is a major problem. Therefore, 
they concluded that 4mg/kg Propofol along with Midazolam will be the 
ideal dose, because there is more hemodynamic stability and better 
conditions for LMA insertion. 
Finally, they concluded that, Midazolam when used with Propofol 
decreased the actual dose requirement for inserting LMA and is an 
effective pre-medication in children. 
 
9. In 2011, Gauchan S6 and his colleagues have done a study comparing 
Propofol and Thiopentone as induction agent for Laryngeal Mask Airway 
insertion. 
The study included 60 adult patients both male and female ASA I / II of 
20-60 yrs, posted for elective surgeries under general anaesthesia. They 
compared the response to insertion of LMA following Propofol or 
Thiopentone induction. 
All the patients were randomly divided into 2 groups, A group (n=30) 
received Propofol 2.5mg/kg I V as induction- agent and B group (n=30) 
received Thiopentone 5mg/kg I V as induction- agent. 
The LMA insertion responses like gagging, coughing, limb and head 
movements and laryngospasm were noted. 
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Heart rate and blood pressure were noted before inducing the patient, 
instantaneously after insertion of LMA and at 1, 3,5 and 10 minutes 
after- insertion of LMA. 
They found that, Propofol suppressed upper airway reflexes more easily 
compared to Thiopentone. There was no change in blood pressure while 
heart rate was more in Thiopentone group compared to Propfol group. 
They concluded that, 2.5mg/kg of Propofol is better than 5mg/kg of 
Thiopentone when used for induction during LMA insertion. 
 
10. In 2001, Asha Gupta1 and colleagues have done a comparative study of 
Ketamine+ Propofol, Fentanyl +Propofol and Butorphanol+-Propofol on 
haemodynamic and Laryngeal Mask Airway Insertion Conditions. 
The study was conducted among 90 adult patients who were randomly 
divided into 3 groups: 
Group PK using 0.5mg/kg Ketamine, group PF with Fentanyl 1µg/kg  
and group PB with Butorphanol 20µg/kg .All the three groups were 
followed by induction agent Propofol 2.5 mg/kg.Young's criteria was 
used to assess jaw relaxation and modified Scheme of Lund and Stovener 
for used to assess the overall suitable insertion conditions. 
The mean total dose of Propofol needed for group PK was 160.37 ± 
15.75mg, for group PF 156.22 ± 17.18 mg and for group PB 140.08 ± 
18.97 mg. The incidence of adequate jaw relaxation was maximum in 
group PB (93.33%) patients, intermediate with group PF (53.33%) 
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patients and minimum in group PK i.e. 36.66% patients. Best insertion 
conditions were detected in 12 patients in group PK and 13 patients in 
group PF and in 26 patients in group PB. Group PK revealed more 
increase in both systolic and diastolic blood pressure and heart rate after 
inserting LMA with compared to group PF and group PB. 
They found that adding Butorphanol with Propofol for inserting LMA 
established absolute jaw relaxation and best insertion situations with 
steady haemodynamics. Side effects like coughing, gagging, lacrimation 
and laryngospasm were found to be lower with respect to other groups. 
 
11. In 2011, Ranju Singh15 et al ,have done a double blinded comparative 
study using Ketamine + Propofol & Fentanyl + Propofol for Laryngeal 
Mask Airway-insertion among 100 ASA I &II children. 
They divided the sample into two groups as Group F,n=50 receiving 
Fentanyl 2µg/kg and Group K, n=50, receiving Ketamine 0.5mg/kg 
before induction with Propofol 3.5mg/kg. They graded LMA insertion 
using 6 subjective endpoints and also studied the hemodynamic response 
just before induction, immediately before LMA insertion and at 1, 3 and 
5 mins after LMA insertion. 
In their study, they concluded that, Fentanyl with Propofol combination 
provided ideal insertion condition in children than Ketamine with 
Propofol combination. 
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12. Tanmoy Ghatak21 and his colleagues have done a study , to analyse the 
outcome of Ketamine+ Propofol, Fentanyl+ Propofol or Saline +Propofol 
on hemodynamic response and LMA insertion conditions in children pre-
medicated with oral Clonidine 
The study group comprised of children of about 180 in the age group of 
2-10 yrs. Oral clonidine (4 μg/kg) was given as pre-medication 90 
minutes prior to surgery, and then were assigned to be given either 
Ketamine 0.5 mg/kg (n=60), Fentanyl 1 μg/kg (n=60) or 0.9% normal 
saline (n=60) prior to induction with Propofol 3.0 mg/kg. LMA was 
inserted within 1 minute following Propofol injection. 
Heart rate and mean blood pressure were observed, 1 min prior to 
induction (baseline), just after induction and after insertion of LMA till  
3mins. After LMA insertion, 6 variables were observed, including 
adequate mouth opening, coughing, swallowing, laryngospasm, ease of 
LMA insertion and patient’s movement. Total insertion score was 
prepared based on these endpoints.  
Ketamine and Fentanyl group showed a significantly better LMA 
insertion summed score (P<0.004) and was comparable in both groups 
than saline. Mean blood pressure and heart rate maintained, in Ketamine 
than other groups. Incidence of sustained apnoea was more in Fentanyl 
group than the other groups. 
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They concluded that, adding Ketamine to Propofol provided stable 
hemodynamic status and less sustained apnoea. It was found to have 
similar adequate insertion conditions for LMA in both the groups. 
 
13. In 2012, Ritu Goyal ,Manpreet Singh17 and colleagues have done a 
comparative study to evaluate Propofol co-induction with Fentanyl or 
Ketamine with respect to hemodynamic stability and adverse effects 
among 60 adult patients undergoing minor surgeries of short duration. 
The study groups were assigned to receive either Ketamine (0.5mg/kg) or 
Fentanyl (1.5µ/kg) as co-induction agent, with Propofol 2.5mg/kg given 
2 minutes later. After LMA insertion, anaesthesia was maintained with 
60% N20 with O2 and intermittent bolus of Propofol (0.5mg/kg). Change 
in heart rate, blood pressure, lacrimation, sweating and abnormal 
movements were observed. 
They found significant decrease in heart rate and blood pressure 
(P<0.005) in Fentanyl group at 1, 3 and 5 min and insignificant change at 
10th min. They also found the incidence of apnoea more in Fentanyl 
group (P<0.05) and none of the patients in their study had laryngospasm 
and the pain due to Propofol injection was not significant. 
They concluded that, in view of haemodynamic stability and adverse 
effects, Ketamine is a better premedicant compared to Fentanyl. Even 
though, the respiratory depression and apnoea is more with Fentanyl, the 
recovery was faster. 
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14. In 2013, Gamal T Yousef5 and his colleagues have done a study 
comparing ketofol (Ketamine and Propofol admixture) with Propofol as 
induction agent on quality of insertion of laryngeal mask airway and 
hemodynamic stability in children 
The study included 100 children of ASA Grade I & II (3-12 years) posted 
for pediatric surgeries under general anaesthesia. They divided the 
sample into two groups; group P (n=50)Propofol 2mg/kg and Group KP 
(n=50) 0.75mg/kg of Ketamine and 1.5mg/kg of Propofol with 20ml 
syringe each group. 
Monitoring with bispectral index (BIS), induction was done with any of 
the above two agents until the BIS values drops to 40. Mean arterial 
pressure (MAP), heart rate (HR) were recorded every 30 seconds upto 5 
minutes after LMA insertion. The time taken for the BIS value to drop to 
40 was noted. Children were observed for incidence of apnea, injection 
pain, adequate jaw relaxation, LMA insertion condition, and 
complications like muscle rigidity, hallucinations, and increased 
secretions. 
The time to achieve induction (to reach BIS 40) was rapid in the group 
KP (150 +/-23.5 seconds) than in the group P (205 +/-37.4 seconds). The 
incidence of injection pain was considerably lesser in the group KP 
(10%) compared to group P(80%). Adequate relaxation of jaw and 
complete mouth opening were greater in the group KP (90%) compared 
to group P (76%). 
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Excellent jaw relaxation and full mouth opening was present with 
Ketofol compared to Propofol. 
They concluded that, Ketofol is an effective and safe substitute as an 
inducing agent for inserting LMA in children due to its faster onset of 
action and found to have lesser occurrence of pain due to injection. It 
provided better conditions for inserting LMA, with decreased 
hemodynamic changes, and lesser apnoea time than Propofol alone. 
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MATERIALS AND METHODS 
STUDY DESIGN 
Prospective, randomized, double blinded, comparative study 
 
STUDY POPULATION 
This study was conducted in the day care surgery theatre, Institute of 
Child Health and Hospital for Children, an attached institution of Madras 
Medical College over a period of three months. 
 
SAMPLE SIZE CALCULATION: 
Sample size was determined based on the study “Randomized, Double-
Blind Comparison of Ketamine + Propofol and Fentanyl + Propofol for the 
Insertion of Laryngeal Mask Airway in Children authored by Ranju Singh, 
Madhur Arora, and Homay Vajifdar published in Journ Anaesthesiol Clin 
Pharmacol. 2011 Jan Mar; 27(1): 91–96. 
In this study the incidence of apnoea with respect to success of LMA 
insertion in first attempt was published to be higher in the Fentanyl group 
(80%) compared to patients of Ketamine group(50%) with difference- 30%. 
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Description: 
 The estimated confidence level is 95% 
 Z-value of 1.96 
 The confidence interval (or)margin of error is estimated to be at +/- 
10 
 Assuming the 80% of the sample, will have the specified feature 
p%=80 and q%=20 
n = p% x q% x [z/e%] ² 
n= 80x 20 x [1.96/5]² 
n= 62 
Therefore 62 is the lowest sample size, possibly required for the study 
(n=31 in intervention arm and n=31 in control arm) 
So a sample size of 70 is taken in this study. 
A prospective, randomized, double -blinded controlled study was 
conducted on 70 ASA I & II children of both the sex, aging 3 -12 years 
undergoing elective surgery under general anaesthesia with spontaneous 
breathing using LMA. 
INCLUSION CRITERIA: 
 Age 3-12 years  
 ASA :I& II 
 Elective Surgeries 
 Informed consent by the parents or guardians of the patients. 
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EXCLUSION CRITERIA: 
 ASA III & I V 
 Patients not satisfying inclusion criteria. 
 Patients who are at risk of aspiration. 
  Patients with Airway abnormalities 
 In patients with anticipated difficult airway. 
 Reactive airway diseases. 
 Known asthmatic 
 Known egg allergy. 
 Seizure disorder 
 Neuro muscular diseases. 
MATERIALS: 
LMA - 2 size and 2.5 size, 16G, 20 G IV Cannula 
Drugs-Propofol, Ketamine, Fentanyl, Oral Midazolam, Emergency drugs  
Ringer Lactate 
Monitors – Cuff pressure monitor, ECG, NIBP, SPO2 
 
METHODS 
 After getting ethical committee clearance,70 children were enrolled for 
the study over a period of three months. Preoperative assessment, 
investigations and evaluation were done. Informed consent got from the 
parents. 
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 Children were fasted 6hrs for solids and 4hrs for fluids. Oral 
Midazolam 0.5mg/kg, was given as premedication, 30mins prior to 
induction of anaesthesia. Midazolam (5mg/ml) IV preparation was 
mixed with honey in a syringe and given to all children, as oral 
preparation was not available. 
 All children were monitored using sedation score : 
Grade I:anxious;agitated 
Grade II: oriented;calm, and co-operative 
Grade III: drowsy; responding to verbal commands 
Grade IV: responds to painful stimuli, but not to oral commands  
GradeV: does not respond to painful stimuli 
Most of the children were under grade II sedation (57 out of 70).IV 
access was obtained in the dorsum of the hand with 22 G cannula without any 
agitation because of quietening effect of oral Midazolam 
 In the operation theatre, baseline parameters like heart rate (HR),blood 
pressure(NIBP) and oxygen saturation (SPO2) were recorded. 
Inj.glycopyrrrolate (0.005mg/kg) was given i.v 5 mins, prior to the 
administration of test drug. Patients were selected randomly by sealed 
envelope into 2 groups: Group F-Fentanyl group (n=35) and Group K-
Ketamine group (n=35) as per the calculated doses based on body 
weight both Fentanyl and Ketamine were taken and subsequently 
diluted in normal saline. It was diluted to 10 ml by a blinded observer 
not involved in the study. 
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 Fentanyl of 2µg/kg was injected intravenously to group F over 10 
seconds and 0.5mg/kg of Ketamine was injected intravenously to group 
K over 10 seconds. 
 Pre-oxygenation was done with 100% oxygen for 3 minutes. Heart rate, 
blood pressure, SpO2 and respiratory rate were observed. Both the 
groups were induced with intravenous Propofol (prepared in a 10 ml 
syringe with 1 ml of 1% preservative free Lidocaine) in the dose of 
2.5mg/kg was given over 15 seconds. 
 Heart rate, blood pressure, SPO2 and respiratory rate were observed. 
After 90 seconds of start of Propofol injection, LMA (size selected 
according to body weight) was inserted by standard finger insertion 
technique. 
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 Cuff inflated with air to maintain a cuff pressure of not more than  
60cms of H2O ideally kept at 45cm of H2O using cuff pressure 
monitor. 
 
 
 
 Also HR, BP, SPO2 and RR noted just before LMA insertion. 
 
The LMA insertion conditions assessed by six variables using three point 
scale: 
Resistance to mouth-opening Nil/ significant/undue force required 
Resistance to insertion easy/difficult/impossible 
Swallowing Nil/slight/gross 
Coughing/gagging nil/slight/gross 
Limb/head movements nil/slight/gross 
Laryngospasm nil/partial/total 
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The number of attempts at LMA insertion noted 
1. If any malposition or difficulty of insertion was found, the LMA was 
removed, additional dose of Propofol (1mg/kg) was given and 
reinsertion was attempted after 60 seconds. Three failed attempts 
amount to insertion failure. The backup plan was direct laryngoscopy 
and endotracheal intubation with appropriate size. 
2. Positioning and airway patency checked by patients respiratory 
movement, chest expansion and capnography.The definite placement of 
LMA was confirmed with Fibre optic bronchoscope. 
 
Fibre optic bronchoscope introduction through LMA 
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Fibreoptic view of epiglottis and vocal cord 
 
After successful LMA insertion, patients were assessed for spontaneous 
respiration. Assisted ventilation was done via LMA, when apnea occurred 
(i.e, cessation of respiration for > 30 seconds), for maintaining the SPO2 > 95% 
till spontaneous respiration is established. The apnoea time was recorded. 
Prolonged apnoea is cessation of spontaneous respiration for > 5 minutes. 
Caudal block of 0.25% Bupivacaine-1ml/kg was given for analgesia to 
both the groups. 
The caudal block failure was evaluated by hemodynamic response, 
when there is an upsurge in HR &SBP by 20% of baseline to surgical incision). 
Anaesthesia was maintained using a Jackson Rees Circuit with nitrous oxide& 
oxygen in the ratio of 2:1 and Sevoflurane of 1-2 % is used. 
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The following parameters were observed 
Heart rate(HR),Systolic blood pressure(SBP),Diastolic blood 
pressure(DBP),Mean blood pressure(MBP),Respiratory rate(RR) and Oxygen 
saturation(SpO2),and ECG were monitored continuously. 
The parameters were noted at subsequent intervals: 
 Baseline parameter 
 Immediately before induction of anaesthesia 
 Immediately before LMA insertion 
 1 minute after insertion of LMA 
 Thereafter at 3 and 5 minutes after LMA insertion 
 
 At the end of the surgery, the device was removed in a deep plane and a 
face mask was used. 
 After patient became conscious, he/she was shifted to the recovery room 
 Patients were observed till discharge for both intraoperative and 
postoperative complications like laryngospasm, bronchospasm, blood 
staining of the device, stridor, hoarseness of voice or painful phonation. 
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STATISTICAL ANALYSIS: 
Descriptive statistics was done for all data and were reported in terms of 
mean values and percentages. Suitable statistical tests of comparison were 
done. Continuous variables were analyzed with the help of unpaired t-test. 
Categorical variables were analyzed with the help of Chi-Square Test and 
Fisher- Exact Test. Statistical significance was taken as P < 0.05. The data was 
analyzed using SPSS version 16 and Microsoft Excel 2007. 
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OBSERVATION AND RESULTS 
TABLE 1-Age  
 
 
Age 
Distribution 
Ketamine + 
Propofol Group % 
Fentanyl + 
Propofol Group % 
≤ 3 years 5 14.29 6 17.14 
4-6 years 25 71.43 19 54.29 
7-9 years 4 11.43 10 28.57 
> 9 years 1 2.86 0 0.00 
Total 35 100 35 100 
  
5
25
4
1
6
19
10
0
0
5
10
15
20
25
30
≤ 3 years 4-6 years 7-9 years > 9 years
N
um
be
r  
of
  S
ub
je
ct
s
Age Distribution
Ketamine + Propofol Group Fentanyl + Propofol Group
 53 
Age Distribution Ketamine + Propofol Group Fentanyl + Propofol Group 
N 35 35 
Mean 4.89 5.50 
Sd 1.76 1.74 
P value Unpaired t Test 0.1507 
 
Majority of the Ketamine + Propofol Group patients belonged to the 4-6 
years age class interval (n=25, 71.43%) with a mean age of 4.89 years. In the 
Fentanyl + Propofol Group patients, majority belonged to the 4-6 years age 
class interval (n=19, 54.29%) with a mean age of 5.50 years. The association 
between the intervention groups and age distribution is considered to be not 
statistically significant since p > 0.05 as per 2 tail unpaired t test. 
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TABLE 2-ASA 
 
 
ASA Physical 
Classification System 
Ketamine + 
Propofol 
Group 
% 
Fentanyl + 
Propofol 
Group 
% 
ASA 1 27 77.14 25 71.43 
ASA 2 8 22.86 10 28.57 
Total 35 100 35 100 
P value Chi Squared Test 0.2991 
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Majority of the Ketamine + Propofol Group patients belonged to the 
ASA 1 class interval (n=27, 77.14%). In the Fentanyl + Propofol Group 
patients, majority belonged to the ASA 1 class interval (n=25, 71.43%). The 
association between the intervention groups and ASA physical classification is 
considered to be not statistically significant since p > 0.05 as per Chi squared 
test. 
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TABLE 3-Height  
 
 
Height 
Distribution 
Ketamine + 
Propofol Group % 
Fentanyl + 
Propofol Group % 
≤ 0.9 mts 9 25.71 4 11.43 
1.0-1.1 mts 20 57.14 21 60.00 
1.2-1.3 mts 6 17.14 10 28.57 
0 0 0.00 0 0.00 
Total 35 100 35 100 
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Height Distribution Ketamine + Propofol Group 
Fentanyl + Propofol 
Group 
N 35 35 
Mean 1.03 1.06 
SD 0.11 0.10 
P value Unpaired t Test 0.2263 
 
Majority of the Ketamine + Propofol Group patients belonged to the 1.0-
1.1 mts height class interval (n=20, 57.14%) with a mean height of 1.03 mts. In 
the Fentanyl + Propofol Group patients, majority belonged to the 1.0-1.1 mts 
height class interval (n=21, 60%) with a mean height of 1.06 mts. The 
association between the intervention groups and height distribution is 
considered to be not statistically significant since p > 0.05 as per 2 tail unpaired 
t test. 
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TABLE 4 –BMI 
 
 
BMI 
Distribution 
Ketamine + 
Propofol Group % 
Fentanyl + 
Propofol Group % 
Underweight  
(≤ 18.49) 33 94.29 35 100.00 
Normal (18.50 to 
24.99) 2 5.71 0 0.00 
Overweight  
(25 to 29.99) 0 0.00 0 0.00 
Obese 0 0.00 0 0.00 
Total 35 100 35 100 
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BMI Distribution Ketamine + Propofol Group 
Fentanyl + Propofol 
Group 
N 35 35 
Mean 12.95 13.59 
SD 2.02 1.53 
P value Unpaired t 
Test 0.1417 
 
Majority of the Ketamine + Propofol Group patients belonged to the 
underweight BMI class interval (n=33, 94.29%) with a mean BMI of 12.95. In 
the Fentanyl + Propofol Group patients, majority belonged to the underweight 
BMI class interval (n=35, 100%) with a mean BMI of 13.59. The association 
between the intervention groups and BMI distribution is considered to be not 
statistically significant since p > 0.05 as per 2 tail unpaired t test. 
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TABLE 5-LMA Insertion Ease 
 
 
LMA Insertion 
Ease 
Ketamine + 
Propofol 
Group 
% 
Fentanyl + 
Propofol 
Group 
% 
Satisfactory 21 60.00 33 94.29 
Difficult 14 40.00 2 5.71 
Total 35 100 35 100 
P value Fishers Exact Test 0.0007 
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Results  
In patients belonging to Ketamine + Propofol Group, the satisfactory 
LMA insertion procedure was 60% (n=21). In Fentanyl + Propofol Group, the 
satisfactory LMA insertion procedure was 94.29% (n=33). The increased 
percentage of satisfactory LMA insertion procedure in Fentanyl + Propofol 
Group compared to the Ketamine + Propofol Group is statistically significant 
as the p value is 0.0007 as per fisher’s exact test indicating a true difference 
among study groups.  
The percentage of satisfactory LMA insertion procedure was 
significantly more in Fentanyl + Propofol Group compared to Ketamine + 
Propofol Group by 34.29 percentage points. This significant difference of 1.57 
times increase in percentage of satisfactory LMA insertion procedure in 
Fentanyl + Propofol Group compared to Ketamine + Propofol Group is true 
and has not occurred by chance.  
Satisfactory LMA insertion was significantly and consistently more in 
Fentanyl + Propofol Group compared to Ketamine + Propofol Group, when 
used for Laryngeal Mask Airway insertion in Children. 
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TABLE 6: LMA Insertion Attempts 
 
 
LMA Insertion 
Attempts 
Ketamine + 
Propofol Group % 
Fentanyl + 
Propofol Group % 
One 29 82.86 32 91.43 
Two 6 17.14 3 8.57 
Total 35 100 35 100 
P value Fishers Exact Test 0.3139 
 
Ketamine + Propofol Group patients had 1 attempt on successful LMA 
insertion (n=29, 82.86%). In the Fentanyl + Propofol Group patients, majority 
patients had one attempt on successful LMA insertion (n=32, 91.43%). The 
association between the intervention groups and LMA insertion attempts is 
considered to be statistically not significant since p value is greater than 0.05 as 
per fishers-exact test.  
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TABLE 7- Problems during LMA Insertion 
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LMA 
Insertion 
Problems 
Ketamine 
+ Propofol 
Group 
% 
Fentanyl 
+ 
Propofol 
Group 
% 
P value 
Fishers 
Exact Test 
Nil 21 60.00 33 94.29 REF 
Limb 
Movements 8 22.86 1 2.86 0.0148 
Resist to 
Insertion 5 14.29 0 0.00 0.0268 
Gagging 1 2.86 1 2.86 0.9999 
Total 35 100 35 100  
 
Results  
In patients belonging to Ketamine + Propofol Group, limb movement 
was the main LMA insertion problem noted (n=8, 22.86%). In Fentanyl + 
Propofol Group too, the limb movement was the main LMA insertion problem 
(n=1, 2.86%). The decreased percentage of limb movement is the main LMA 
insertion problem in Fentanyl + Propofol Group compared to the Ketamine + 
Propofol Group which is statistically significant as the p value is 0.0148 as per 
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fishers exact test indicating a true difference among study groups. Similarly the 
percentage of resistance to insertion is found to be decreased in Fentanyl + 
Propofol Group compared to the Ketamine + Propofol Group, which is 
statistically significant as the p value is 0.0268 as per fishers-exact test 
indicating a true difference among study groups.  
The percentage of limb movement as the main LMA insertion 
complication was statistically less in Fentanyl + Propofol Group compared to 
Ketamine + Propofol Group by 22 percentage points. This significant 
difference of 87% decrease in percentage of limb movement as the main LMA 
insertion complication in Fentanyl + Propofol Group compared to Ketamine + 
Propofol Group is true and has not occurred by chance.  
The percentage of resistance to insertion as the other LMA insertion 
complication was statistically less in Fentanyl + Propofol Group compared to 
Ketamine + Propofol Group by 14.29 percentage points. This significant 
difference of 100% decrease in percentage of resistance to insertion as the other 
LMA insertion complication in Fentanyl + Propofol Group compared to 
Ketamine + Propofol Group is true and has not occurred by chance 
LMA insertion complication like limb movements and resistance to 
insertion were significantly and consistently lower in Fentanyl + Propofol 
Group compared to Ketamine + Propofol Group when used in insertion of 
Laryngeal Mask Airway in Children .  
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Table 8 - Systolic Blood Pressure (SBP) 
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Systolic Blood 
Pressure Baseline Pre Ind 
Pre 
LMA 1 min 3 Mins 5 Mins 
Ketamine + 
Propofol 
Group 
N 35 35 35 35 35 35 
Mean 101.06 109.03 92.94 91.40 90.83 92.60 
SD 8.80 8.60 10.97 7.03 8.92 10.49 
Fentanyl + 
Propofol 
Group 
N 35 35 35 35 35 35 
Mean 103.40 98.60 84.46 85.69 88.00 88.26 
SD 9.04 10.36 9.02 8.23 9.45 9.10 
P value Unpaired 
T Test 0.2759 0.0000 0.0008 0.0027 0.0022 0.0488 
 
By conventional criteria the association between the intervention groups 
and SBP status among study subjects is considered to be statistically significant 
since p < 0.05.  
 68 
Results  
In patients belonging to Ketamine + Propofol Group, the mean SBP is 
96.31 mm Hg. In Fentanyl + Propofol Group the mean SBP is 91.40 mm Hg. 
The increased the mean SBP measurement in Ketamine + Propofol Group 
compared to the Fentanyl + Propofol Group is statistically significant as the p 
value is 0.0000, 0.0008, 0.0027, 0.0022 and 0.0488 between preinduction and 5 
minutes on induction as per unpaired t- test indicating a true difference among 
study groups. 
The mean SBP measurement was statistically more in Ketamine + 
Propofol Group compared to the Fentanyl + Propofol Group by 1.05 times with 
a mean difference of 4.91 mm Hg  
This difference is true and significant and has not occurred by chance. 
The mean systolic blood pressure measurement was significantly and 
consistently higher in Ketamine + Propofol Group compared to the Fentanyl + 
Propofol when used in insertion of Laryngeal Mask Airway in Children  
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Table 9: Diastolic Blood Pressure (DBP) 
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Diastolic Blood 
Pressure Baseline 
Pre 
Ind 
Pre 
LMA 1min  3Mins 5 Mins 
Ketamine + 
Propofol 
Group 
N 35 35 35 35 35 35 
Mean 63.20 66.80 58.43 53.60 53.94 55.26 
SD 9.01 8.36 8.80 7.64 8.31 9.61 
Fentanyl + 
Propofol 
Group 
N 35 35 35 35 35 35 
Mean 66.29 61.77 50.46 48.97 51.37 51.00 
SD 10.11 8.62 8.05 6.71 8.08 7.99 
P value Unpaired 
T Test 0.1822 0.0157 0.00022 0.0089 0.0140 0.0480 
 
By conventional criteria the association between the intervention groups 
and DBP status among study subjects is considered to be statistically 
significant since p < 0.05.   
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Results  
In patients belonging to Ketamine + Propofol Group, the mean DBP is 
58.54 mm Hg. In Fentanyl + Propofol Group the mean DBP is 54.98 mm Hg. 
The increase in the mean DBP measurement in Ketamine + Propofol Group 
compared to the Fentanyl + Propofol Group is statistically significant as the p 
value is 0.0157, 0.0002, 0.0089, 0.0140 and 0.0480 between preinduction and 5 
minutes on induction as per unpaired t- test indicating a true difference among 
study groups. 
The mean DBP measurement was statistically more in Ketamine + 
Propofol Group compared to the Fentanyl + Propofol Group by 1.06 times with 
a mean difference of 3.56 mm Hg  
This difference is true and significant and has not occurred by chance. 
The mean diastolic blood pressure measurement was significantly and 
consistently higher in Ketamine + Propofol Group compared to the Fentanyl + 
Propofol when used in insertion of Laryngeal Mask Airway in Children  
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Table 10: Respiratory Rate (RR) 
 
 
Respiratory Rate Baseline Pre Induction 
Pre 
LMA 
1 
Minute 
3 
Minutes 
5 
Minutes 
Ketamine + 
Propofol 
Group 
N 35 34 34 34 35 35 
Mean 18.60 20.50 18.85 24.38 24.11 22.34 
SD 3.47 3.63 5.23 5.81 4.01 3.16 
Fentanyl + 
Propofol 
Group 
N 35 32 32 34 35 35 
Mean 17.83 16.69 14.19 18.15 19.43 18.89 
SD 3.66 3.91 4.46 5.06 5.16 3.79 
P value Unpaired  
T Test 0.3689 0.0001 0.0002 0.0000 0.0001 0.0001 
 
By conventional criteria the association between the intervention groups 
and respiratory rate status among study subjects is considered to be statistically 
significant since p < 0.05.   
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Results  
In patients belonging to Ketamine + Propofol Group, the mean RR is 
21.47. In Fentanyl + Propofol Group the mean DBP is 17.53. The increased the 
mean RR measurement in Ketamine + Propofol Group compared to the 
Fentanyl + Propofol Group is statistically significant as the p value is 0.0001, 
0.0002, and 0.0000 between preinduction and 5 minutes on induction as per 
unpaired t- test indicating a true difference among study groups.  
The mean RR measurement was more in Ketamine + Propofol Group 
compared to the Fentanyl + Propofol Group by 1.22 times with a mean 
difference of 3.94 breaths per minute. 
This difference is true and significant and has not occurred by chance. 
The mean respiratory rate measurement was significantly and 
consistently higher in Ketamine + Propofol Group compared to the Fentanyl + 
Propofol when used in insertion of Laryngeal Mask Airway in Children  
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Table 11: Apnoea 
 
 
Apnoea 
Time 
Ketamine + 
Propofol Group % 
Fentanyl + 
Propofol Group % 
≤ 2 minutes 4 80.00 9 75.00 
2.01-5 
minutes 1 20.00 2 16.67 
> 5 minutes 0 0.00 1 8.33 
Total 5 100 12 100 
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Apnoea Time Ketamine + Propofol Group Fentanyl + Propofol Group 
N 5 12 
Mean 98.00 122.92 
SD 113.00 131.09 
P value Unpaired t Test 0.0025 
 
Results  
In patients belonging to Ketamine + Propofol Group, the mean apnoea 
time is. 98.00 seconds. In Fentanyl + Propofol Group, the mean apnoea time is 
112.92 seconds.. The increased mean apnoea time in Fentanyl + Propofol 
Group compared to the Ketamine + Propofol Group is statistically significant 
as the p value is 0.0025 as per unpaired t- test indicating a true difference 
among study groups. Also, only 8.33% of Fentanyl + Propofol showed 
prolonged apnoea> 5mins which is statistically insignificant. 
The mean apnoea time was more in Fentanyl + Propofol Group 
compared to Ketamine + Propofol Group by 24.92 seconds. This significant 
difference of 1.25 times increase in mean apnoea time in Fentanyl + Propofol 
Group compared to Ketamine + Propofol Group is true and has not occurred by 
chance.  
The mean apnoea time was significantly and consistently higher in 
Fentanyl + Propofol Group compared to Ketamine + Propofol Group when 
used in insertion of Laryngeal Mask- Airway in Children   
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Table 12: LMA Extubation Complications 
 
 
LMA 
Extubation 
Complications 
Ketamine + 
Propofol 
Group 
% 
Fentanyl + 
Propofol 
Group 
% P value Fishers Exact Test 
Nil 31 88.57 35 100.00 REF 
Blood Stain 1 2.86 0 0.00 0.9999 
Cough 3 8.57 0 0.00 0.1196 
Total 35 100 35 100  
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Majority of the Ketamine + Propofol Group patients had cough as the 
main LMA extubation complication (n=3, 8.57%). In the Fentanyl + Propofol 
Group patients, majority patients had no LMA extubation complication  
(n=35, 100%). The association between the intervention groups and LMA 
extubation complications is considered to be not statistically significant since p 
> 0.05 as per fishers exact test. 
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DISCUSSION 
Endotracheal intubation is a routine procedure to conduct general 
anaesthesia and also a secured way of having a control over airway. But 
laryngoscopy and tracheal intubation, produce stress response that leads to 
reflex surge in sympatho-adrenal activity .This causes a raise in heart rate and 
blood pressure leading to dysarrhythmias, which are lethal to cardiac patients. 
Face masks are routinely used for short surgical procedures during 
induction and maintenance under TIVA (Total intravenous anaesthesia) and for 
volatile induction. But it has the disadvantage of holding the mask continuously 
in spontaneously breathing patients. 
Laryngeal Mask Airway started gaining popularity as an alternative to 
endotracheal intubation as well as facemask because it causes less 
hemodynamic changes, associated with negligible raise in intraocular pressure 
after inserting LMA, causes decreased incidence of sore throat and also frees 
the hands of the anaesthesiologist to perform other important tasks during the 
surgical procedures. It also provides a beneficial outcome especially in ENT 
and ophthalmic surgeries where excessive straining is potentially harmful, as it 
has a low incidence of coughing during emergence. 
Even for the inexperienced provider, the LMA acts as an excellent 
airway device in many clinical areas that includes the emergency room, the 
operating room, and in ambulatory care as it is easy to handle even by 
untrained hands. Nearly 100% success rate for LMA placement occurs in the 
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operating room. A lower rate of achievement for LMA placement may be 
expected in the emergency setting. 
Use of LMA in children is becoming increasingly common. To achieve 
easy LMA insertion, obtundation of airway reflexes is a must, so that coughing, 
gagging, head and limb movements or laryngospasm can be avoided Sufficient 
depth of anaesthesia is needed for adequate mouth opening. Succinylcholine 
can be used for suppressing these sequelae, but with the disadvantage of 
muscle pain. Propofol is currently used as induction agent for LMA insertion, 
as it depresses airway reflexes more than Thiopentone. However, when 
Propofol is used alone higher doses are required to reduce pharyngeal and 
laryngeal reflexes which might cause cardiac depression and also makes LMA 
insertion conditions unsatisfactory. 
Combination therapy termed as co-induction, may provide enhanced 
effects, more of desired effect rather than adverse effects, with minimal costs. 
Recently, in various anaesthetic procedures, the concept of co-induction has 
been proved better. Various combinations of drugs like Propofol-Fentanyl, 
Propofol-Ketamine, Propofol-Midazolam have been tried. 
Comparisons have been made between Propofol 2.5mg/kg with Fentanyl 
2µg/kg and Propofol 2.5mg/kg with Ketamine 0.5mg/kg with reference to ideal 
LMA insertion conditions. 
In my study, the insertion conditions of LMA were observed on the 
basis of 6 variables such as resistance to mouth opening, resistance to insertion, 
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swallowing, coughing, gagging, limb and head movements and laryngospasm 
as proposed in Sivalingam et al and Cheam et al study. In our study the patients 
showed 94.29 % satisfactory insertion condition with Fentanyl + Propofol 
group compared to Ketamine + Propofol with 60%. 
The frequent variable that we encountered was limb and head 
movements that too especially limb movements. The higher incidence of head 
and limb movements in Group Propofol + Ketamine could be due to the 
combined effects of excitatory movements caused by Propofol and increased 
muscle tone caused by Ketamine. Also the incidence of head and limb 
movements in Group PF (2.86%) was less compared to Group Propofol + 
Ketamine (22.86%) with p<0.0148 which is significant. Ranju Singh et al, in 
their study also found that a statistically highly significant head and limb 
movements (p=0.007) were encountered in Group PK(Propofol+Ketamine) 
compared to Group PF (Propofol+Fentanyl).  
The study done by Goh PK et al, showed greater occurrence of head and limb 
movement in Ketamine group( 40% ) than Fentanyl group (16%), the incidence 
was more than what we noted. There was no laryngospasm in both the groups 
in our study. This has been supported by the study done by Ranju Singh et al, 
which showed nil occurrence of laryngospasm 
Group Propofol + Fentanyl had adequate (100%) jaw relaxation 
showing nil case of resistance to insertion with 14.29% resistance to insertion 
in Group Propofol + Ketamine of p<0.0268. Our results are consistent with the 
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study conducted by Asha Gupta and Sarabjit Kaur in which they compared jaw 
relaxation according to Young’s criteria. Their results showed that the 
incidence of absolute jaw relaxation was highest in Group PB (Propofol + 
Butarphanol) - 28(93.33%), intermediate in Group PF (Propofol + Fentanyl) -
53.33% and lowest in Group PK(Propofol + Ketamine) -11 patients (36.66%). 
Tanmoy Ghatak et al, also compared the efficiency of Ketamine +Propofol, 
Fentanyl + Propofol or Saline + Propofol for hemodynamic features and 
insertion conditions for LMA in children premedicated with oral Clonidine. 
Ketamine and Fentanyl group showed a significantly better LMA insertion 
summed score (P<0.004) and was similar in both the groups than saline group. 
But the dose of Fentanyl they used was 1µg/kg. In a study by Gamal T Yousef 
et al, used Ketofol as induction agent ,that lead to adequate jaw relaxation and 
adequate mouth opening in the KP group i.e., Ketamine + Propofol {n=45 
(90%)}than in the Propofol group {n=38(76%)}. 
Bah J et al, studied ideal insertion conditions with different doses of 
Propofol along with Ketamine + Lidocaine spray for inserting LMA. The study 
concluded that, dosage more than 3 mg/kg of Ketamine achieved satisfactory 
degree of jaw relaxation. 
Goh PK et al in his study reported 23% of patients in Fentanyl group 
required additional bolus dose of Propofol compared to 10% of patients in 
Ketamine group. Our study showed only 8.5% of patients in Fentanyl group 
required additional bolus dose of Propofol with second attempt, compared to 
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17.1% of patients in Ketamine group. He has also reported that inserting LMA 
and resistance to mouth opening was found to be higher in Fentanyl group. 
The incidence of coughing/gagging between the two groups was not 
significant in our study. There was higher occurrence of coughing & gagging in 
KP Group (Ketamine-Propofol),of the study conducted by Asha Gupta et al, 
compared to Fentanyl-Propofol and Butorphanol-Propofol. 
The overall insertion ease was significantly good with Group PF 
compared to Group PK (p=0.0007) 
Statistically, a high incidence of apnoea was observed in Group PF with 
p<0.0025 in our study. Supporting our study, the study conducted by Asha 
Gupta et al, the incidence of apnoea was greater with Propofol – Fentanyl 
compared to Propofol-Butorphanol because of Butorphanol receptor specificity 
and µ antagonism. The incidence is greatest with Group PF and also the mean 
duration of apnoea was greatest with Group PF. Also the study conducted by 
Cheam EWS and Chui PT et al, showed that Fentanyl improved the conditions 
during Laryngeal Mask Airway insertion, but showed prolonged duration of 
apnoea. Study conducted by Ranju Singh et al, showed more incidence of 
apnoea with 40 children out of 50 in Fentanyl group (80%) compared to 25 
children out of 50 in Ketamine group (50%). Also in my study, prolonged 
apnoea was shown in 1 child out of 35 with Fentanyl group compared to none 
in Ketamine group. But study conducted by Raju Singh et al, showed 
prolonged apnoea in Ketamine + Propofol group (14%) as compared to 
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Fentanyl + Propofol group (12%).In the study conducted by Goh PK et al, the 
occurrence of sustained apnoea was higher in group Fentanyl (23.1%) than 
group Ketamine( 6.3%). Sustained apnoea happened more with Fentanyl than 
Ketamine or saline group by Gatak et al study. 
The apnoea caused by either Fentanyl or Ketamine has little clinical 
significance and this parameter may in fact allow enough time in checking the 
LMA position after insertion by manual ventilation. 
Kodaka et al noted that a Fentanyl dose of 0.5 µg/kg is adequate to 
reduce predicted EC-50LMA (the effective concentration for 50% of the 
attempts to secure laryngeal maskinsertion of Propofol using a target‐controlled 
infusion with minimum respiratory depression and without a high BIS value.) 
In our study, the baseline parameters like heart rate (p=0.7), systolic 
blood pressure (SBP) (p=0.264) and diastolic blood pressure (DBP) (p=0.182) 
were same for the both the groups. Group PK showed a significant rise in 
systolic, diastolic blood pressure and mean arterial pressure during pre-
induction, pre LMA insertion, 1 min after LMA insertion and 3 mins after 
LMA insertion. This effect of Ketamine is due to indirect sympathomimetic 
action on sinus node. Our results were similar with those of Ranju Singh et al 
in which Ketamine showed higher mean arterial pressure throughout the study 
period as compared to the Fentanyl group. Studies done by Goh PK et al, 
Ghataket aland Asha Gupta et al also showed similar results supporting our 
study.  
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Heart rate was found to be higher in Group PK compared to Group PF in 
our study .This similar outcome was observed in studies of Goh Pk etal, Ghatak 
et al and Asha Gupta et al.  
Pain while injecting Propofol is considered as a negligible complication, 
but it might lead to uncooperation and distress to the child. Pain can be due to 
activation of kininogens or by the free aqueous concentration of Propofol in the 
emulsion. 
In our study, pain following Propofol injection was similar in all the 
groups and was statistically insignificant between two groups. This was 
analogous to the study done by Ritu Goyal et al. The study done by Ritu Sinha 
also found that, apart from addition of Propofol with Lignocaine (preservative 
free), Thiopentone mixed with Propofol causes decreased release of kinins and 
altered pH in admixture preventing injection pain during Propofol . 
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SUMMARY 
Various combination of adjuncts such as Ketamine-Propofol, Fentanyl-
Propofol, Midazolam –Propofol ,Lignocaine+Ketamine along with Propofol, 
Butorphanol-Propofol, Mivacurium-Propofol and 1:1 ratio Propofol-
Thiopentone have been tried to find out the ideal LMA insertion conditions 
with minimal haemodynamic response. But, there are limited studies with 
respect to LMA insertion in children. 
Since children have large volume of distribution, the dose of Propofol 
required to achieve adequate plane of anaesthesia will be more. To avoid the 
cardio-depressant effect of Propofol, co-induction study comparing Propofol-
Fentanyl Vs Propofol-Ketamine was conducted. 
A prospective, randomized, double- blinded, case control study been 
conducted among 70 children between 3 to 12 years of both genders belonging 
to ASA I & II posted for elective surgery under general anaesthesia 
maintaining spontaneous respiration using LMA. Ideal LMA insertion 
condition was evaluated and compared with children induced with Ketamine-
Propofol Vs Fentanyl-Propofol. Propofol in the dose of 2.5 mg/kg was given to 
both the groups. Group PK received Ketamine of 0.5 mg/kg and Group- PF 
received Fentanyl of 2µg/kg. LMA was inserted 90 seconds after Propofol 
injection and the insertion was evaluated based on 6 variables. Heart rate (HR), 
systolic blood pressure (SBP), diastolic pressure (DBP) and mean arterial 
pressure (MAP) were noted. Also the occurrence of apnoea was noted. 
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Results: 
1. The incidence of head and limb movements was less in Group Propofol + 
Fentanyl compared to Group Propofol+ Ketamine with p value of 0.0148 
2. Coughing or gagging was seen in 2.86% of both the groups.  
3. Resistance to insertion was statistically significant with p value of 0.0268 
showing more in Propofol + Ketamine group. 
4. There was no statistical significance in the occurrence of restricted mouth 
opening, restriction to LMA insertion and occurrence of swallowing 
between the two groups. 
5. Laryngospasm was absent in either groups. 
6. Fentanyl group showed the incidence of more apnoea compared to 
Ketamine group. 
7. The heart rate (HR0, systolic blood pressure(SBP), diastolic blood 
pressure(DBP) and mean arterial pressure(MAP) were statistically more 
with Ketamine group than Fentanyl group. 
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CONCLUSION 
In this study, I conclude that co-induction with Fentanyl (2µg/kg) prior 
to Propofol (2.5 mg/kg) for insertion of Laryngeal Mask Airway in children 
provided better insertion conditions and minimal alteration in haemodynamic 
parameters than co-induction with Ketamine (0.5 mg/kg) and Propofol         
(2.5 mg/kg). 
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